Your browser doesn't support javascript.
loading
[Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
Li, Y X; Yin, Q S; Ai, H; Mi, R H; Zhang, L N; Li, Y F; Wei, X D; Song, Y P.
Afiliación
  • Li YX; Department of Medicine, the First People's Hospital of Zhengzhou, Zhengzhou 450000.
  • Yin QS; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Ai H; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Mi RH; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Zhang LN; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Li YF; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Wei XD; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Song YP; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhonghua Yi Xue Za Zhi ; 99(8): 605-610, 2019 Feb 26.
Article en Zh | MEDLINE | ID: mdl-30818930

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Burkitt Tipo de estudio: Guideline / Observational_studies Límite: Adolescent / Child / Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Burkitt Tipo de estudio: Guideline / Observational_studies Límite: Adolescent / Child / Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2019 Tipo del documento: Article